Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chengyi Tu
Observed name:
Tu, Chengyi
Institutions:
Stanford Medicine,
Stanford Cardiovascular Institute,
The University of Texas Southwestern Medical Center,
Stanford University
Observed institutions:
Stanford Medicine,
Institute for Stem Cell Biology and Regenerative Medicine,
Stanford Cardiovascular Institute,
Clemson University,
The University of Texas at Austin,
The University of Texas Southwestern Medical Center,
Stanford University
show all 7
ORCID:
0000-0002-8947-6237
Observed ORCID:
0000-0002-8947-6237
OpenAlex ID:
A5070174640
Works
30
Awards
3
Generation of Quiescent Cardiac Fibroblasts From Human Induced Pluripotent Stem Cells for In Vitro Modeling of Cardiac Fibrosis
2019
·
Hao Zhang
, Lei Tian
, et al.
·
Circulation Research
·
193
Strategies for Improving the Maturity of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
2018
·
Chengyi Tu
, Benjamin S. Chao
, et al.
·
Circulation Research
·
119
PDF
Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target
2024
·
Hao Zhang
, Phung N. Thai
, et al.
·
Cell
·
99
Nanoscale Strategies: Treatment for Peripheral Vascular Disease and Critical Limb Ischemia
2015
·
Chengyi Tu
, Subhamoy Das
, et al.
·
ACS Nano
·
73
Tachycardia-induced metabolic rewiring as a driver of contractile dysfunction
2023
·
Chengyi Tu
, Arianne Caudal
, et al.
·
Nature Biomedical Engineering
·
43
PDF
Quantifying the Vasculogenic Potential of Induced Pluripotent Stem Cell-Derived Endothelial Progenitors in Collagen Hydrogels
2019
·
Cody O. Crosby
, Deepti Valliappan
, et al.
·
Tissue Engineering Part A
·
38
Contractility and Calcium Transient Maturation in the Human iPSC-Derived Cardiac Microfibers
2022
·
Dovile Strimaityte
, Chengyi Tu
, et al.
·
ACS Applied Materials & Interfaces
·
34
Protocol to measure contraction, calcium, and action potential in human-induced pluripotent stem cell-derived cardiomyocytes
2021
·
Joe Z. Zhang
, Shane Rui Zhao
, et al.
·
STAR Protocols
·
27
PDF
Transcriptome analysis of non human primate-induced pluripotent stem cell-derived cardiomyocytes in 2D monolayer culture vs. 3D engineered heart tissue
2020
·
Huaxiao Yang
, Ningyi Shao
, et al.
·
Cardiovascular Research
·
27
PDF
Gene Transfection for Stem Cell Therapy
2016
·
Kiheon Baek
, Chengyi Tu
, et al.
·
Current Stem Cell Reports
·
25
PDF
Temporal Impact of Substrate Anisotropy on Differentiating Cardiomyocyte Alignment and Functionality
2019
·
Alicia C.B. Allen
, Elissa Barone
, et al.
·
Tissue Engineering Part A
·
23
Human Induced Pluripotent Stem Cells as a Screening Platform for Drug-Induced Vascular Toxicity
2021
·
Chengyi Tu
, Nathan J. Cunningham
, et al.
·
Frontiers in Pharmacology
·
21
PDF
Improving the engraftment and integration of cell transplantation for cardiac regeneration
2019
·
Chengyi Tu
, Racheal Mezynski
, et al.
·
Cardiovascular Research
·
20
Human induced pluripotent stem cells for studying mitochondrial diseases in the heart
2022
·
Arianne Caudal
, Lu Ren
, et al.
·
FEBS Letters
·
18
Glycogen synthase kinase-3 inhibition sensitizes human induced pluripotent stem cells to thiol-containing antioxidants induced apoptosis
2017
·
Chengyi Tu
, Robert Xu
, et al.
·
Stem Cell Research
·
14
PDF
Moving iPSC-Derived Cardiomyocytes Forward to Treat Myocardial Infarction
2018
·
Chengyi Tu
, Janet Zoldan
·
Cell stem cell
·
12
PDF
Monitoring protein synthesis in single live cancer cells
2016
·
Chengyi Tu
, Loredana Santo
, et al.
·
Integrative Biology
·
12
Modeling heart rhythm using human engineered heart tissues
2025
·
Chengyi Tu
, Arianne Caudal
, et al.
·
Nature Protocols
·
11
PDF
Commonly used thiol-containing antioxidants reduce cardiac differentiation and alter gene expression ratios of sarcomeric isoforms
2018
·
Chengyi Tu
, Alicia Allen
, et al.
·
Experimental Cell Research
·
8
Validating and Using Cardiac NAMs for Toxicity Screening and Drug Development
2025
·
Jennifer Beck Pierson
, Anthony Bahinski
, et al.
·
International Journal of Toxicology
·
6
A transcriptomic atlas of drug-induced endothelial dysfunction in human endothelial cells
2022
·
Chengyi Tu
, Yu Liu
, et al.
·
Journal of Molecular and Cellular Cardiology
·
6
PDF
Targeting an atypical G protein–coupled receptor signaling pathway for cardiac fibrosis therapy
2026
·
Hao Zhang
, Rabindra V. Shivnaraine
, et al.
·
Science
·
2
Cell Village Captures Populational Heterogeneity of Sunitinib Cardiotoxicity
2026
·
Ana Kojic
, Yu Liu
, et al.
·
Circulation Research
·
1
PDF
Modeling Heart Failure With Preserved Ejection Fraction Using Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes
2026
·
Brian Yu
, Lu Ren
, et al.
·
Circulation
·
1
Abstract Or202: Multiscale Platform Identifies Novel Therapeutic Targets for Fibrosis
2025
·
Hao Zhang
, Rabindra Shivnaraine
, et al.
·
Circulation Research
·
1
Show more works
View as search
Works count:
30
Citation count:
854
H-index:
14
I10-index:
18
Year
Topic
Type